415 related articles for article (PubMed ID: 29284495)
1. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.
Giladi M; Munster M; Schneiderman RS; Voloshin T; Porat Y; Blat R; Zielinska-Chomej K; Hååg P; Bomzon Z; Kirson ED; Weinberg U; Viktorsson K; Lewensohn R; Palti Y
Radiat Oncol; 2017 Dec; 12(1):206. PubMed ID: 29284495
[TBL] [Abstract][Full Text] [Related]
2. Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines.
Karanam NK; Srinivasan K; Ding L; Sishc B; Saha D; Story MD
Cell Death Dis; 2017 Mar; 8(3):e2711. PubMed ID: 28358361
[TBL] [Abstract][Full Text] [Related]
3. Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study.
Bokstein F; Blumenthal D; Limon D; Harosh CB; Ram Z; Grossman R
Front Oncol; 2020; 10():411. PubMed ID: 32373508
[No Abstract] [Full Text] [Related]
4. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
Guberina N; Pöttgen C; Kebir S; Lazaridis L; Scharmberg C; Lübcke W; Niessen M; Guberina M; Scheffler B; Jendrossek V; Jabbarli R; Pierscianek D; Sure U; Schmidt T; Oster C; Hau P; Grosu AL; Stuschke M; Glas M; Nour Y; Lüdemann L
Radiat Oncol; 2020 Apr; 15(1):83. PubMed ID: 32307022
[TBL] [Abstract][Full Text] [Related]
5. The dielectric properties of skin and their influence on the delivery of tumor treating fields to the torso: a study combining in vivo measurements with numerical simulations.
Hershkovich HS; Urman N; Yesharim O; Naveh A; Bomzon Z
Phys Med Biol; 2019 Sep; 64(18):185014. PubMed ID: 31323651
[TBL] [Abstract][Full Text] [Related]
6. DNA repair after irradiation in glioma cells and normal human astrocytes.
Short SC; Martindale C; Bourne S; Brand G; Woodcock M; Johnston P
Neuro Oncol; 2007 Oct; 9(4):404-11. PubMed ID: 17704360
[TBL] [Abstract][Full Text] [Related]
7. Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.
Connelly J; Hormigo A; Mohilie N; Hu J; Chaudhry A; Blondin N
BMC Cancer; 2016 Nov; 16(1):842. PubMed ID: 27809808
[TBL] [Abstract][Full Text] [Related]
8. Tumor treating fields: a new frontier in cancer therapy.
Davies AM; Weinberg U; Palti Y
Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
[TBL] [Abstract][Full Text] [Related]
9. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of tumor-treating fields in preclinical glioma models.
Silginer M; Weller M; Stupp R; Roth P
Cell Death Dis; 2017 Apr; 8(4):e2753. PubMed ID: 28425987
[TBL] [Abstract][Full Text] [Related]
11. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
Wang Y; Pandey M; Ballo MT
Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Impact of a Tumor Treating Fields Device for Glioblastoma Patients Undergoing Simultaneous Radiation Therapy.
Li T; Shukla G; Peng C; Lockamy V; Liu H; Shi W
Front Oncol; 2018; 8():51. PubMed ID: 29594036
[TBL] [Abstract][Full Text] [Related]
13. Acceptance and compliance of TTFields treatment among high grade glioma patients.
Onken J; Staub-Bartelt F; Vajkoczy P; Misch M
J Neurooncol; 2018 Aug; 139(1):177-184. PubMed ID: 29644485
[TBL] [Abstract][Full Text] [Related]
14. Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy.
Karanam NK; Ding L; Aroumougame A; Story MD
Transl Res; 2020 Mar; 217():33-46. PubMed ID: 31707040
[TBL] [Abstract][Full Text] [Related]
15. Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma.
Lacouture ME; Anadkat MJ; Ballo MT; Iwamoto F; Jeyapalan SA; La Rocca RV; Schwartz M; Serventi JN; Glas M
Front Oncol; 2020; 10():1045. PubMed ID: 32850308
[No Abstract] [Full Text] [Related]
16. Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.
Voloshin T; Kaynan N; Davidi S; Porat Y; Shteingauz A; Schneiderman RS; Zeevi E; Munster M; Blat R; Tempel Brami C; Cahal S; Itzhaki A; Giladi M; Kirson ED; Weinberg U; Kinzel A; Palti Y
Cancer Immunol Immunother; 2020 Jul; 69(7):1191-1204. PubMed ID: 32144446
[TBL] [Abstract][Full Text] [Related]
17. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
[TBL] [Abstract][Full Text] [Related]
18. Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.
Reichert S; Rödel C; Mirsch J; Harter PN; Tomicic MT; Mittelbronn M; Kaina B; Rödel F
Radiother Oncol; 2011 Oct; 101(1):51-8. PubMed ID: 21852011
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas - a planning study.
Straube C; Oechsner M; Kampfer S; Scharl S; Schmidt-Graf F; Wilkens JJ; Combs SE
Radiat Oncol; 2018 Feb; 13(1):31. PubMed ID: 29471879
[TBL] [Abstract][Full Text] [Related]
20. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A
PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
